Literature DB >> 17950809

Adverse drug events in hospitalized cardiac patients.

John Fanikos1, Jennifer L Cina, Steven Baroletti, Karen Fiumara, Lina Matta, Samuel Z Goldhaber.   

Abstract

Little information is available concerning adverse drug events (ADEs) in cardiac patients. Therefore, the investigators report the results of cardiac patients in an ADE surveillance program, with the intent of reducing the frequency of future events. All reported adverse drug reactions and medication errors in cardiac patients over a 5-year period at Brigham and Women's Hospital were reviewed. There were 547 ADEs in cardiac patients, a rate of 1.9 events for every 100 patient admissions. Preventable ADEs most often occurred during medication administration (34.2%), with wrong rate or frequency of medication administration the most widespread event. Cardiovascular agents (29.8%), anticoagulants (28.5%), and antimicrobial agents (10.8%) were the most common drug classes associated with ADEs. Injury or prolonged hospitalization occurred in 5.3% of patients. ADEs occurred most frequently on the admission day, on weekdays, and in the early morning hours. Peak frequencies of ADEs coincided with nursing shift changes. In conclusion, ADEs occur often in hospitalized cardiac patients and affect 2 of every 100 patient admissions. Given the high percentage of ADEs associated with drug administration, more resources should be directed at this step of medication use. Focusing interventions around nursing shift changes may further enhance preventive strategies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17950809     DOI: 10.1016/j.amjcard.2007.06.041

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  11 in total

1.  Anticoagulation-associated adverse drug events.

Authors:  Gregory Piazza; Thanh Nha Nguyen; Deborah Cios; Matthew Labreche; Benjamin Hohlfelder; John Fanikos; Karen Fiumara; Samuel Z Goldhaber
Journal:  Am J Med       Date:  2011-12       Impact factor: 4.965

2.  Extracting medications and associated adverse drug events using a natural language processing system combining knowledge base and deep learning.

Authors:  Long Chen; Yu Gu; Xin Ji; Zhiyong Sun; Haodan Li; Yuan Gao; Yang Huang
Journal:  J Am Med Inform Assoc       Date:  2020-01-01       Impact factor: 4.497

3.  Factors associated with iatrogenesis in neonatal intensive care units: an observational multicenter study.

Authors:  Einav Srulovici; Liora Ore; Eric S Shinwell; Shraga Blazer; Shmuel Zangen; Arieh Riskin; David Bader; Amir Kugelman
Journal:  Eur J Pediatr       Date:  2012-07-28       Impact factor: 3.183

Review 4.  Implementation of inpatient models of pharmacogenetics programs.

Authors:  Larisa H Cavallari; Craig R Lee; Julio D Duarte; Edith A Nutescu; Kristin W Weitzel; George A Stouffer; Julie A Johnson
Journal:  Am J Health Syst Pharm       Date:  2016-12-01       Impact factor: 2.637

5.  Nucleic acid scavengers inhibit thrombosis without increasing bleeding.

Authors:  Shashank Jain; George A Pitoc; Eda K Holl; Ying Zhang; Luke Borst; Kam W Leong; Jaewoo Lee; Bruce A Sullenger
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-25       Impact factor: 11.205

6.  Development of universal antidotes to control aptamer activity.

Authors:  Sabah Oney; Ruby T S Lam; Kristin M Bompiani; Charlene M Blake; George Quick; Jeremy D Heidel; Joanna Yi-Ching Liu; Brendan C Mack; Mark E Davis; Kam W Leong; Bruce A Sullenger
Journal:  Nat Med       Date:  2009-10-04       Impact factor: 53.440

7.  Adverse drug reactions to anticoagulants in Spain: analysis of the Spanish National Hospital Discharge Data (2010-2013).

Authors:  P Carrasco-Garrido; V Hernández-Barrera; J Esteban-Hernández; I Jiménez-Trujillo; A Álvaro-Meca; A López de Andrés; J de Miguel Diez; J M Rodríguez Barrios; J A Muñoz Robles; R Jiménez-García
Journal:  BMJ Open       Date:  2017-01-10       Impact factor: 2.692

8.  Selection of an aptamer antidote to the anticoagulant drug bivalirudin.

Authors:  Jennifer A Martin; Parag Parekh; Youngmi Kim; Timothy E Morey; Kwame Sefah; Nikolaus Gravenstein; Donn M Dennis; Weihong Tan
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

9.  Anticoagulant and Antithrombotic Properties of Three Structurally Correlated Sea Urchin Sulfated Glycans and Their Low-Molecular-Weight Derivatives.

Authors:  Ariana A Vasconcelos; Isabela D Sucupira; Alessandra L Guedes; Ismael N Queiroz; Flavia S Frattani; Roberto J Fonseca; Vitor H Pomin
Journal:  Mar Drugs       Date:  2018-08-30       Impact factor: 5.118

10.  Epidemiology of Adverse Events and Medical Errors in the Care of Cardiology Patients.

Authors:  Yoshinori Ohta; Izumi Miki; Takeshi Kimura; Mitsuru Abe; Mio Sakuma; Kaoru Koike; Takeshi Morimoto
Journal:  J Patient Saf       Date:  2019-09       Impact factor: 2.844

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.